
(State or Other Jurisdiction of Incorporation) | (I.R.S. Employer Identification No.) |
Title of each class | Trading Symbol | Name of each exchange on which registered | ||
Page No. | ||
Condensed Consolidated Balance Sheets — March 31, 2026 and December 31, 2025 | ||
Condensed Consolidated Statements of Operations — Three Months Ended March 31, 2026 and 2025 | ||
Condensed Consolidated Statements of Comprehensive Loss — Three Months Ended March 31, 2026 and 2025 | ||
Condensed Consolidated Statements of Stockholders’ Equity — Three Months Ended March 31, 2026 and 2025 | ||
Condensed Consolidated Statements of Cash Flows — Three Months Ended March 31, 2026 and 2025 | ||
Exhibit Index | ||
•our belief that our PX offers market-leading value with the highest technological and economic benefit; |
•our belief that leveraging our pressure exchanger technology will unlock new commercial opportunities in the future; |
•our belief that our technology helps our customer achieve environmentally sustainable operations; |
•our expectation that sales outside of the U.S. will remain a significant portion of our revenue; |
•the scale of the environmental impact from the use of our solutions; |
•the timing of our receipt of payment for products or services from our customers; |
•our belief that our existing cash and cash equivalents, our short and/or long-term investments, and the ongoing cash generated from our operations, will be sufficient to meet our anticipated liquidity needs for the foreseeable future, with the exception of a decision to enter into an acquisition and/or fund investments in our latest technology arising from rapid market adoption that could require us to seek additional equity or debt financing; |
•our expectations relating to the amount and timing of recognized revenue from our projects; |
•our expectation that we will continue to receive a tax benefit related to U.S. federal foreign-derived intangible income and research and development tax credit; |
•the outcome of proceedings, lawsuits, disputes and claims; |
•the impact of losses due to indemnification obligations; |
•other factors disclosed under the MD&A and Part I, Item 3, “Quantitative and Qualitative Disclosures about Market Risk,” and elsewhere in this Form 10-Q. |
March 31, 2026 | December 31, 2025 | ||
(In thousands) | |||
ASSETS | |||
Current assets: | |||
Cash and cash equivalents | $ | $ | |
Short-term investments | |||
Accounts receivable, net | |||
Inventories, net | |||
Prepaid expenses and other assets | |||
Total current assets | |||
Long-term investments | |||
Deferred tax assets, net | |||
Property and equipment, net | |||
Operating lease, right of use asset | |||
Goodwill | |||
Other assets, non-current | |||
Total assets | $ | $ | |
LIABILITIES AND STOCKHOLDERS’ EQUITY | |||
Current liabilities: | |||
Accounts payable | $ | $ | |
Accrued expenses and other liabilities | |||
Lease liabilities | |||
Contract liabilities | |||
Total current liabilities | |||
Lease liabilities, non-current | |||
Other liabilities, non-current | |||
Total liabilities | |||
Commitments and contingencies (Note 7) | |||
Stockholders’ equity: | |||
Common stock | |||
Additional paid-in capital | |||
Accumulated other comprehensive loss | ( | ( | |
Treasury stock | ( | ( | |
Retained earnings | |||
Total stockholders’ equity | |||
Total liabilities and stockholders’ equity | $ | $ | |
Three Months Ended March 31, | |||
2026 | 2025 | ||
(In thousands, except per share data) | |||
Revenue | $ | $ | |
Cost of revenue | |||
Restructuring - inventory reserve | |||
Gross profit | |||
Operating expenses: | |||
General and administrative | |||
Sales and marketing | |||
Research and development | |||
Restructuring charges | |||
Impairment of goodwill | |||
Total operating expenses | |||
Loss from operations | ( | ( | |
Other income: | |||
Interest income | |||
Other non-operating income, net | |||
Total other income, net | |||
Loss before income taxes | ( | ( | |
Benefit from income taxes | ( | ( | |
Net loss | $( | $( | |
Net loss per share: | |||
Basic and diluted | $ ( | $ ( | |
Number of shares used in per share calculations: | |||
Basic and diluted | |||
Three Months Ended March 31, | ||||
2026 | 2025 | |||
(In thousands) | ||||
Net loss | $( | $( | ||
Other comprehensive loss, net of tax | ||||
Foreign currency translation adjustments | ( | ( | ||
Unrealized loss on investments | ( | ( | ||
Total other comprehensive loss, net of tax | ( | ( | ||
Comprehensive loss | $( | $( | ||
Three Months Ended March 31, | |||
2026 | 2025 | ||
(In thousands, except shares) | |||
Common stock | |||
Beginning balance | $ | $ | |
Issuance of common stock | |||
Ending balance | |||
Additional paid-in capital | |||
Beginning balance | |||
Issuance of common stock | |||
Shares held for tax withholdings | ( | ( | |
Stock-based compensation | |||
Ending balance | |||
Accumulated other comprehensive (loss) income | |||
Beginning balance | ( | ||
Other comprehensive loss | |||
Foreign currency translation adjustments | ( | ( | |
Unrealized loss on investments | ( | ( | |
Total other comprehensive loss, net | ( | ( | |
Ending balance | ( | ||
Treasury stock | |||
Beginning balance | ( | ( | |
Common stock repurchased | ( | ( | |
Ending balance | ( | ( | |
Retained earnings | |||
Beginning balance | |||
Net loss | ( | ( | |
Ending balance | |||
Total stockholders’ equity | $ | $ | |
Common stock issued (shares) | |||
Beginning balance | |||
Issuance of common stock | |||
Ending balance | |||
Treasury stock (shares) | |||
Beginning balance | |||
Common stock repurchased | |||
Ending balance | |||
Total common stock outstanding (shares) | |||
Beginning Balance | |||
Issuance of common stock | |||
Common stock repurchased | ( | ( | |
Ending Balance | |||
Three Months Ended March 31, | |||
2026 | 2025 | ||
(In thousands) | |||
Cash flows from operating activities: | |||
Net loss | $( | $( | |
Adjustments to reconcile net loss to cash provided by operating activities | |||
Stock-based compensation | |||
Depreciation and amortization | |||
Accretion (amortization) of discounts (premiums) on investments | ( | ( | |
Deferred income taxes | ( | ( | |
Impairment of long-lived assets | |||
Impairment of goodwill | |||
Restructuring - inventory reserve | |||
Other non-cash adjustments | ( | ||
Changes in operating assets and liabilities: | |||
Accounts receivable, net | |||
Contract assets | ( | ||
Inventories, net | ( | ( | |
Prepaid and other assets | ( | ||
Accounts payable | |||
Accrued expenses and other liabilities | ( | ( | |
Contract liabilities | |||
Net cash provided by operating activities | |||
Cash flows from investing activities: | |||
Maturities of marketable securities | |||
Purchases of marketable securities | ( | ( | |
Capital expenditures | ( | ( | |
Proceeds from sales of fixed assets | |||
Net cash (used in) provided by investing activities | ( | ||
Cash flows from financing activities: | |||
Net proceeds from issuance of common stock | |||
Tax payment for employee shares withheld | ( | ( | |
Repurchase of common stock | ( | ( | |
Payment of excise tax associated with repurchase of common stock | ( | ||
Net cash used in financing activities | ( | ( | |
Effect of exchange rate differences on cash and cash equivalents | ( | ||
Net change in cash, cash equivalents and restricted cash | |||
Cash, cash equivalents and restricted cash, beginning of year | |||
Cash, cash equivalents and restricted cash, end of period | $ | $ | |
Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 | ||||||||||||||
Desalination | Wastewater | Emerging Technologies | Total | Desalination | Wastewater | Emerging Technologies | Total | ||||||||
(In thousands) | |||||||||||||||
Geographical market | |||||||||||||||
Middle East | $ | $ | $ | $ | $ | $ | $ | $ | |||||||
Africa | $ | ||||||||||||||
Other | $ | ||||||||||||||
Total revenue | $ | $ | $ | $ | $ | $ | $ | $ | |||||||
Channel | |||||||||||||||
Original equipment manufacturer | $ | $ | $ | $ | $ | $ | $ | $ | |||||||
Aftermarket | $ | ||||||||||||||
Megaproject | $ | ||||||||||||||
Total revenue | $ | $ | $ | $ | $ | $ | $ | $ | |||||||
March 31, 2026 | December 31, 2025 | |||
(In thousands) | ||||
Accounts receivable, net | $ | $ | ||
Contract assets, current (included in prepaid expenses and other assets) | $ | $ | ||
Contract liabilities: | ||||
Contract liabilities, current | $ | $ | ||
Total contract liabilities | $ | $ | ||
March 31, 2026 | December 31, 2025 | ||
(In thousands) | |||
Contract liabilities, beginning of year | $ | $ | |
Revenue recognized | ( | ( | |
Cash received, excluding amounts recognized as revenue during the period | |||
Contract liabilities, end of period | $ | $ | |
Period | Remaining Performance Obligations | ||
(In thousands) | |||
2026 (remaining nine months) | $ | ||
2027 | |||
Total | $ |
Three Months Ended March 31, | |||
2026 | 2025 | ||
(In thousands, except per share amounts) | |||
Numerator | |||
Net loss | $( | $( | |
Denominator (weighted average shares) | |||
Basic and dilutive common shares outstanding | |||
Diluted common shares outstanding | |||
Loss Per Share | |||
Basic and dilutive | $ ( | $ ( | |
Three Months Ended March 31, | |||
2026 | 2025 | ||
(In thousands) | |||
Anti-dilutive equity award shares | |||
March 31, 2026 | December 31, 2025 | March 31, 2025 | |||
(In thousands) | |||||
Cash and cash equivalents | $ | $ | $ | ||
Restricted cash, non-current (included in other assets, non-current) | |||||
Total cash, cash equivalents and restricted cash | $ | $ | $ | ||
March 31, 2026 | December 31, 2025 | ||
(In thousands) | |||
Raw materials | $ | $ | |
Work in process | |||
Finished goods | |||
Inventories, gross | |||
Valuation adjustments for excess and obsolete inventory | ( | ( | |
Inventories, net | $ | $ | |
March 31, 2026 | December 31, 2025 | ||
(In thousands) | |||
Accrued expenses and other liabilities, current | |||
Payroll, benefits, incentives and commissions payable | $ | $ | |
Warranty reserve | |||
Restructuring accrual | |||
Income taxes payable | |||
Other accrued expenses and other liabilities | |||
Total accrued expenses and other liabilities | |||
Other liabilities, non-current | |||
Total accrued expenses, and current and non-current other liabilities | $ | $ | |
Severance and Benefits | |
(In thousands) | |
Balance, as of December 31, 2024 | $ |
Restructuring provision, net of adjustments | |
Cash paid | ( |
Balance, as of December 31, 2025 | $ |
Restructuring provision | |
Cash paid | ( |
Balance, as of March 31, 2026 | $ |
March 31, 2026 | December 31, 2025 | ||||||||
Pricing Category | Amortized Cost | Fair Value | Amortized Cost | Fair Value | |||||
(In thousands) | |||||||||
Cash equivalents | |||||||||
Money market securities | Level 1 | $ | $ | $ | $ | ||||
U.S. treasury securities | Level 2 | ||||||||
Total cash equivalents | |||||||||
Short-term investments | |||||||||
U.S. treasury securities | Level 2 | ||||||||
Corporate notes and bonds | Level 2 | ||||||||
Total short-term investments | |||||||||
Long-term investments | |||||||||
U.S. treasury securities | Level 2 | ||||||||
Corporate notes and bonds | Level 2 | ||||||||
Total long-term investments | |||||||||
Total short and long-term investments | |||||||||
Total | $ | $ | $ | $ | |||||
Three Months Ended March 31, | |||
2026 | 2025 | ||
(In thousands, except percentages) | |||
Benefit from income taxes | $( | $( | |
Discrete items | ( | ||
Benefit from income taxes, excluding discrete items | $( | $( | |
Effective tax rate | |||
Effective tax rate, excluding discrete items | |||
Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 | ||||||||||||||||||
Desalination | Wastewater | Emerging Technologies | Corporate | Total | Desalination | Wastewater | Emerging Technologies | Corporate | Total | ||||||||||
(In thousands) | |||||||||||||||||||
Revenue | $ | $ | $ | $ | $ | $ | $ | $ | $ | $ | |||||||||
Cost of revenue | |||||||||||||||||||
Restructuring - inventory reserve | |||||||||||||||||||
Gross profit (loss) | ( | ( | |||||||||||||||||
Operating expenses | |||||||||||||||||||
General and administrative | |||||||||||||||||||
Sales and marketing | |||||||||||||||||||
Research and development | |||||||||||||||||||
Restructuring charges | |||||||||||||||||||
Impairment of goodwill | |||||||||||||||||||
Total operating expenses | |||||||||||||||||||
Operating income (loss) | $( | $( | $( | $( | $( | $ | $( | $( | $( | $( | |||||||||
Three Months Ended March 31, | ||||
2026 | 2025 | |||
Product revenue by country:(1) | ||||
Cyprus | ** | |||
Egypt | ** | |||
India | ** | |||
Others(2) | ||||
Total | ||||
Three Months Ended March 31, | |||||
Segment | 2026 | 2025 | |||
Customer A | Desalination | ** | |||
Customer B | Desalination | ** | |||
Number of Shares Purchased | Average Price Paid per Share(1) | Plan Activity | |||||
(In millions) | |||||||
August 2025 Authorization | |||||||
Repurchases under August 2025 Authorization | $ | ( | |||||
Remaining amount under August 2025 Authorization | $ |
Three Months Ended March 31, | |||||||||||
2026 | 2025 | ||||||||||
Revenue | % of Revenue | Revenue | % of Revenue | Change | |||||||
(In thousands, except percentages) | |||||||||||
Original equipment manufacturer | $6,588 | 68% | $4,001 | 50% | $2,587 | 65% | |||||
Aftermarket | 2,754 | 28% | 4,028 | 50% | (1,274) | (32%) | |||||
Megaproject | 364 | 4% | 36 | —% | 328 | 911% | |||||
Total revenue | $9,706 | 100% | $8,065 | 100% | $1,641 | 20% | |||||
Three Months Ended March 31, | |||||||||||||||
2026 | 2025 | ||||||||||||||
Desalination | Wastewater | Emerging Technologies | Total | Desalination | Wastewater | Emerging Technologies | Total | ||||||||
(In thousands) | |||||||||||||||
Middle East | $2,506 | $— | $77 | $2,583 | $2,014 | $— | $1 | $2,015 | |||||||
Africa | 196 | — | — | 196 | 866 | — | — | 866 | |||||||
Other | 6,205 | 601 | 121 | 6,927 | 4,879 | 305 | — | 5,184 | |||||||
Total revenue | $8,907 | $601 | $198 | $9,706 | $7,759 | $305 | $1 | $8,065 | |||||||
Three Months Ended March 31, | |||||
2026 | 2025 | Change | |||
(In thousands, except percentage and basis point) | |||||
Gross profit | $2,702 | $4,458 | $(1,756) | ||
Gross margin | 27.8% | 55.3% | (2,750) bps | ||
Three Months Ended March 31, | ||||||||||||||||||||
2026 | 2025 | |||||||||||||||||||
Desalination | Wastewater | Emerging Technologies | Corporate | Total | Desalination | Wastewater | Emerging Technologies | Corporate | Total | |||||||||||
(In thousands) | ||||||||||||||||||||
General and administrative | $756 | $981 | $348 | $4,370 | $6,455 | $845 | $728 | $755 | $6,246 | $8,574 | ||||||||||
Sales and marketing | 2,485 | 1,163 | 858 | 613 | 5,119 | 2,108 | 1,037 | 1,270 | 491 | 4,906 | ||||||||||
Research and development | 1,616 | 136 | 1,037 | — | 2,789 | 849 | 329 | 1,823 | — | 3,001 | ||||||||||
Restructuring charges | 335 | 18 | 1,140 | 43 | 1,536 | 107 | 103 | 123 | 206 | 539 | ||||||||||
Impairment of goodwill | — | — | 1,662 | — | 1,662 | — | — | — | — | — | ||||||||||
Total operating expenses | $5,192 | $2,298 | $5,045 | $5,026 | $17,561 | $3,909 | $2,197 | $3,971 | $6,943 | $17,020 | ||||||||||
Three Months Ended March 31, | |||
2026 | 2025 | ||
(In thousands) | |||
Interest income | $725 | $1,073 | |
Other non-operating income, net | 108 | 6 | |
Total other income, net | $833 | $1,079 | |
Three Months Ended March 31, | |||
2026 | 2025 | ||
(In thousands, except percentages) | |||
Benefit from income taxes | $(1,775) | $(1,603) | |
Discrete items | (132) | 52 | |
Benefit from income taxes, excluding discrete items | $(1,907) | $(1,551) | |
Effective tax rate | 12.7% | 14.0% | |
Effective tax rate, excluding discrete items | 13.6% | 13.5% | |
Three Months Ended March 31, | |||||
2026 | 2025 | Change | |||
(In thousands) | |||||
Net cash provided by operating activities | $21,037 | $10,678 | $10,359 | ||
Net cash (used in) provided by investing activities | (7,606) | 12,674 | (20,280) | ||
Net cash used in financing activities | (11,376) | (3,874) | (7,502) | ||
Effect of exchange rate differences on cash and cash equivalents | (15) | 33 | (48) | ||
Net change in cash, cash equivalents and restricted cash | $2,040 | $19,511 | $(17,471) | ||
Period | Total Number of Shares Purchased | Average Price Paid per Share(1) | Total Number of Shares Purchased as Part of Publicly Announced Program | Maximum Number of Shares or Approximate Dollar Value(1) That May Yet to be Purchased Under the Program | ||||||
(In thousands) | ||||||||||
January 1 – January 31, 2026 | 109,300 | $14.28 | 109,300 | $17,820 | ||||||
February 1 – February 28, 2026 | 76,153 | $14.66 | 76,153 | $16,703 | ||||||
March 1 – March 31, 2026 | 774,850 | $10.30 | 774,850 | $8,721 |
Exhibit Number | Exhibit Description | |
31.1* | ||
31.2* | ||
32.1** | ||
101 | Inline XBRL Document Set for the consolidated financial statements and accompanying notes in Part I, “Financial Information” of this Quarterly Report on Form 10-Q. | |
104 | Inline XBRL for the cover page of this Quarterly Report on Form 10-Q, included in the Exhibit 101 Inline XBRL Document Set. | |
ENERGY RECOVERY, INC. | |||||
Date: | May 6, 2026 | By: | /s/ DAVID W. MOON | ||
David W. Moon | |||||
President and Chief Executive Officer | |||||
(Principal Executive Officer) | |||||
Date: | May 6, 2026 | By: | /s/ MICHAEL S. MANCINI | ||
Michael S. Mancini | |||||
Chief Financial Officer | |||||
(Principal Financial Officer) | |||||